Immunovant Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Immunovant Contact Number

Immunovant LinkedIn

3 hours ago Linkedin.com Get All

If you have any questions, please contact us at [email protected]immunovant.com. Join Us https://immunovant.com 18 13 Comments Like Comment Share. Immunovant 2,386 followers. 2d Report this post

Website: https://www.linkedin.com/company/immunovant

Category: Contact NumberShow more

Immunovent Crunchbase Company Profile & Funding

Just Now Crunchbase.com Get All

Headquarters Regions Greater New York Area, East Coast, Northeastern US. Founded Date 2013. Operating Status Active. Company Type For Profit. Phone Number 6464948432. Founded by NYC biotech scientists and entrepreneurs, Immunovent, LLC is revolutionizing allergy diagnostics by coupling existing clinical practices with their patented LAMB-Dx test.

Founded: 2013

Website: https://www.crunchbase.com/organization/immunovent

Category: Contact NumberShow more

Immunovant Inc Company Profile and News Bloomberg Markets

Just Now Bloomberg.com Get All

Company profile page for Immunovant Inc including stock price, company news, press releases, executives, board members, and contact information

Website: https://www.bloomberg.com/profile/company/IMVTU:US

Category: Contact NumberShow more

Immunovant Crunchbase Company Profile & Funding

Just Now Crunchbase.com Get All

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Its investigational product candidate, IMVT-1401 (formerly known as RVT-1401), is a novel, fully human monoclonal antibody targeting the neonatal Fc receptor (FcRn). We believe that this product has the potential to.

Website: https://www.crunchbase.com/organization/immunovant

Category: Contact NumberShow more

About Immunovant Inc (IMVT) Investing.com

5 hours ago Investing.com Get All

(917) 580-3099

Get an in-depth profile of Immunovant Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information. Industry

Employees: 68
Phone: (917) 580-3099

Website: https://www.investing.com/equities/immunovant-inc-company-profile

Category: Contact NumberShow more

Immunovant, Inc. Common Stock (IMVT) Institutional

3 hours ago Nasdaq.com Get All

Immunovant, Inc. Common Stock (IMVT) including the number of shares held by those institutions in a firm, along with recent purchases and sales information. Contact Careers

Website: https://www.nasdaq.com/market-activity/stocks/imvt/institutional-holdings

Category: Contact NumberShow more

Immunovant, Inc. (IMVT) Company Profile & Facts Yahoo

5 hours ago Finance.yahoo.com Get All

See the company profile for Immunovant, Inc. (IMVT) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their

Website: https://finance.yahoo.com/quote/IMVT/profile/

Category: Contact NumberShow more

IMVT Immunovant Inc. Company Profile & Executives WSJ

8 hours ago Wsj.com Get All

Company profile for Immunovant Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed IMVT description & address.

Website: https://www.wsj.com/market-data/quotes/IMVT/company-people

Category: Contact NumberShow more

IMVT Immunovant Inc. Stock Price & News WSJ

3 hours ago Wsj.com Get All

Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2021. Press Release. Key Stock Data. P/E Ratio (TTM) The Price to Earnings (P/E

Website: https://www.wsj.com/market-data/quotes/IMVT

Category: Contact NumberShow more

IMVT.OQ Immunovant Inc Key Developments Reuters

8 hours ago Reuters.com Get All

Directory of sites Login Contact Support. Immunovant Reports Financial Results For The Quarter Ended June 30, 2021. Aug 9 (Reuters) - Immunovant Inc …

Website: https://www.reuters.com/companies/IMVT.OQ/key-developments

Category: Contact NumberShow more

IMVT Stock Price Immunovant Inc. Stock Quote (U.S

8 hours ago Marketwatch.com Get All

Immunovant stock price target raised to $34 from $26 at SVB Leerink. Aug. 20, 2020 at 7:21 a.m. ET by Tomi Kilgore. Barron's.

Website: https://www.marketwatch.com/investing/stock/imvt

Category: Contact NumberShow more

Jyotin J. Vyas Vice President, Global Program and

8 hours ago Linkedin.com Get All

Jyotin and I worked closely at Pfizer for a number of years on number of projects and he demonstrated deep knowledge of licensing, management, the company business values, and many other qualities.

Title: Vice President, Global Program …
Location: New York City Metropolitan
1. 500+ connections

Website: https://www.linkedin.com/in/jyotinvyas

Category: Contact NumberShow more

Study of RVT1401 for the Treatment of Patients With

1 hours ago Clinicaltrials.gov Get All

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03922321

Website: https://www.clinicaltrials.gov/ct2/show/NCT03922321

Category: Contact NumberShow more

Immunovant Inc (IMVTQ) Quote The Globe and Mail

4 hours ago Theglobeandmail.com Get All

Immunovant Inc. is a clinical-stage biopharmaceutical company focused on autoimmune diseases. The company's product candidate consists of IMVT-1401 which is a novel, fully human monoclonal

Website: https://www.theglobeandmail.com/investing/markets/stocks/IMVT-Q/

Category: Contact NumberShow more

Document sec.gov

6 hours ago Sec.gov Get All

NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) – Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today reported financial results for its fiscal first quarter ended June 30, 2021.Immunovant ended the quarter with approximately $379 million in cash.

Website: https://www.sec.gov/Archives/edgar/data/1764013/000176401321000077/exhibit991-20210809x8xkq1.htm

Category: Contact NumberShow more

Immunovant, Inc. Common Stock (IMVT) Stock Price, Quote

Just Now Nasdaq.com Get All

917 580-3099

About Immunovant, Inc. 320 WEST 37TH STREET 6TH FLOOR, NEW YORK, New York, 10018, United States +1 917 580-3099. Immunovant Inc is a clinical-stage …

Website: https://www.nasdaq.com/market-activity/stocks/imvt

Category: Contact NumberShow more

Lawsuit filed for Investors in shares of Immunovant, Inc.

1 hours ago Openpr.com Get All

Investors who are current long term investors in Immunovant, Inc. (NASDAQ: IMVT) shares, have certain options and should contact the Shareholders Foundation at [email protected] or

Website: https://www.openpr.com/news/2247546/lawsuit-filed-for-investors-in-shares-of-immunovant-inc

Category: Contact NumberShow more

Immunovant, Inc. (IMVT) Stock Price, News, Quote & History

7 hours ago Finance.yahoo.com Get All

Immunovant Reports Financial Results for the Quarter Ended June 30, 2021. Company Ended the Quarter With Cash of Approximately $379 Million and Subsequently Received a Direct Investment of …

Website: https://finance.yahoo.com/quote/IMVT/

Category: Contact NumberShow more

NASDAQ:IMVT Shareholder Notice: Investigation over

6 hours ago Sbwire.com Get All

Investors who purchased shares of Immunovant, Inc. (NASDAQ: IMVT) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Immunovant, Inc. directors breached their fiduciary duties and caused damage to the company

Website: http://www.sbwire.com/press-releases/nasdaqimvt-shareholder-notice-investigation-over-potential-wrongdoing-at-immunovant-inc-1327910.htm

Category: Contact NumberShow more

Director, Project Management Remote Immunovant, Inc

7 hours ago Theladders.com Get All

Immunovant, Inc. is hiring a Director, Project Management, with an estimated salary of $150,000 - $200,000. This Business Project Management job in Project & Program Management is in Virtual / Travel.

Website: https://www.theladders.com/job/director-project-management-immunovant-inc-virtual-travel_47628364

Category: Contact NumberShow more

Immunovant, Inc. (NASDAQ:IMVT) Investor Notice: Lawsuit

3 hours ago Sbwire.com Get All

(858)-779-1554

Those who purchased shares of Immunovant, Inc. (NASDAQ: IMVT) have certain options and should contact the Shareholders Foundation. Contact: Shareholders Foundation, Inc. Michael Daniels 3111 Camino Del Rio North - Suite 423 92108 San Diego Phone: +1-(858)-779-1554 Fax: +1-(858)-605-5739 [email protected]

Website: http://www.sbwire.com/press-releases/immunovant-inc-nasdaqimvt-investor-notice-lawsuit-alleges-securities-laws-violations-1329875.htm

Category: Contact NumberShow more

Internet Crime Complaint Center (IC3) Cyber Criminals

1 hours ago Ic3.gov Get All

1. Fake Job or Hiring Scams occur when criminal actors deceive victims into believing they have a job or a potential job. Criminals leverage their position as “employers” to persuade victims to provide them with personally identifiable information (PII) or to send them money.

Website: https://www.ic3.gov/Media/Y2020/PSA200121

Category: Contact NumberShow more

Glancy Prongay & Murray LLP, a Leading Securities Fraud

4 hours ago Businesswire.com Get All

If you suffered a loss on your Immunovant investments or would like to inquire about potentially pursuing claims to recover your loss under the …

Website: https://www.businesswire.com/news/home/20210223005436/en/Glancy-Prongay-Murray-LLP-a-Leading-Securities-Fraud-Law-Firm-Announces-Investigation-of-Immunovant-Inc.-fka-Health-Sciences-Acquisitions-Corporation-IMVT-on-Behalf-of-Investors

Category: Contact NumberShow more

Immunovant, Inc. S1/A Feb. 28, 2020 5:24 PM Seeking Alpha

9 hours ago Seekingalpha.com Get All

(917) 580-3099

320 West 37th Street . New York, NY 10018 (917) 580-3099 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Website: https://seekingalpha.com/filing/4985409

Category: Contact NumberShow more

A Study of RVT1401 in Myasthenia Gravis (MG) Patients

1 hours ago Clinicaltrials.gov Get All

The purpose of the current study is to assess safety/tolerability and key pharmacodynamic (PD) effects that are considered to be associated with clinical benefit (reduction of total IgG and anti-AChR-IgG) in Myasthenia Gravis patients following treatment with RVT-1401 (also known as IMVT-1401) compared to placebo. Condition or disease.

Website: https://www.clinicaltrials.gov/ct2/show/NCT03863080

Category: Contact NumberShow more

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

8 hours ago Accesswire.com Get All

888.476.6529

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action]

Website: https://www.accesswire.com/634909/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Reminds-Shareholders-with-Losses-on-their-Investment-in-Immunovant-Inc-fka-Health-Sciences-Acquisitions-Corporation-of-Class-Action-Lawsuit-and-Upcoming-Deadline-IMVT-HSACU-HSAC-and-HSACW

Category: Contact NumberShow more

Immunovant, Inc. (IMVT) Stock Price Today, Quote & News

6 hours ago Seekingalpha.com Get All

A high-level overview of Immunovant, Inc. (IMVT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Website: https://seekingalpha.com/symbol/IMVT

Category: Contact NumberShow more

Investigation announced for NASDAQ: IMVT investors over

Just Now Openpr.com Get All

Investors who are current long term investors in Immunovant, Inc. (NASDAQ: IMVT) shares, have certain options and should contact the Shareholders Foundation at [email protected] or

Website: https://www.openpr.com/news/2283975/investigation-announced-for-nasdaq-imvt-investors-over

Category: Contact NumberShow more

Immunovant Appoints Robert K. Zeldin, M.D. as Chief

8 hours ago Prnewswire.com Get All

/PRNewswire/ — Immunovant, "IMVT-1401 is a promising subcutaneous product candidate with the potential to treat a number of serious and …

Website: https://www.prnewswire.com/news-releases/immunovant-appoints-robert-k-zeldin-md-as-chief-medical-officer-and-w-bradford-middlekauff-jd-as-general-counsel-300900488.html

Category: Contact NumberShow more

Immunovant Announces Redemption of Warrants and

3 hours ago Benzinga.com Get All

These statements are also subject to a number of material risks and uncertainties that are described under the section titled "Risk Factors" in Immunovant's Form 10-Q …

Website: https://www.benzinga.com/pressreleases/20/05/g16030069/immunovant-announces-redemption-of-warrants-and-achievement-of-first-earnout-milestone-under-share

Category: Contact NumberShow more

IMVT Stock quote for IMMUNOVANT, INC. MSN Money

3 hours ago Msn.com Get All

Future Outlook And Stock Price Performance For Immunovant, Inc. (NASDAQ:IMVT) marketingsentinel 6/7/2021. Roivant, in an unexSPACted twist, wants to …

Website: https://www.msn.com/en-us/money/stockdetails/nas-imvt/fi-bql227

Category: Contact NumberShow more

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

8 hours ago Accesswire.com Get All

888.476.6529

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action]

Website: https://www.accesswire.com/638856/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Reminds-Shareholders-with-Losses-on-their-Investment-in-Immunovant-Inc-fka-Health-Sciences-Acquisitions-Corporation-of-Class-Action-Lawsuit-and-Upcoming-Deadline-IMVT-HSACU-HSAC-and-HSACW

Category: Contact NumberShow more

Immunovant Appoints Michael Elliott Chief Scientific

2 hours ago Bloomberg.com Get All

These statements are also subject to a number of material risks and uncertainties that are described under the section titled “Risk Factors” in Immunovant’s Form 10-Q for the quarterly

Website: https://www.bloomberg.com/press-releases/2020-08-24/immunovant-appoints-michael-elliott-chief-scientific-officer

Category: Contact NumberShow more

Glancy Prongay & Murray LLP, a Leading Securities Fraud

3 hours ago Apnews.com Get All

LOS ANGELES--(BUSINESS WIRE)--Feb 25, 2021--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (“HSAC”, “Immunovant”, or the “Company”) (NASDAQ: IMVT) securities …

Website: https://apnews.com/press-release/business-wire/business-products-and-services-ownership-changes-lawsuits-crime-39ed24ecde914dd29ad2b43c01675f9c

Category: Contact NumberShow more

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

7 hours ago Prnewswire.com Get All

888.476.6529

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their

Website: https://www.prnewswire.com/news-releases/shareholder-alert--pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-immunovant-inc-fka-health-sciences-acquisitions-corporation-of-class-action-lawsuit-and-upcoming-deadline--imvt-hsacu-hsac-and--301250571.html

Category: Contact NumberShow more

IMVT: Immunovant Inc Stock Price, Quote and News CNBC

2 hours ago Cnbc.com Get All

Get Immunovant Inc (IMVT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Website: https://www.cnbc.com/quotes/IMVT

Category: Contact NumberShow more

The Law Offices of Frank R. Cruz Announces Investigation

5 hours ago Businesswire.com Get All

The Law Offices of Frank R. Cruz Announces Investigation of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) on Behalf …

Website: https://www.businesswire.com/news/home/20210223005476/en/The-Law-Offices-of-Frank-R.-Cruz-Announces-Investigation-of-Immunovant-Inc.-fka-Health-Sciences-Acquisitions-Corporation-IMVT-on-Behalf-of-Investors

Category: Contact NumberShow more

Immunovant plunges nearly 50% after pausing a trial for

8 hours ago Businessinsider.in Get All

Shares of Immunovant plunged nearly 50% on Tuesday after the company announced a voluntary pause in its ongoing clinical trials for IMVT-1401. The drug, which

Website: https://www.businessinsider.in/stock-market/news/immunovant-plunges-nearly-50-after-pausing-a-trial-for-its-eye-drug-after-unexpected-cholesterol-finding/articleshow/80656501.cms

Category: Contact NumberShow more

IMVT Stock Price & Charts Immunovant

4 hours ago Ycharts.com Get All

7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in …

Website: https://ycharts.com/companies/IMVT

Category: Contact NumberShow more

Immunovant Receives $200 Million Strategic Investment from

9 hours ago Benzinga.com Get All

After giving effect to the investment, Immunovant has a pro forma cash balance of approximately $600 million and Roivant has increased its ownership stake …

Website: https://www.benzinga.com/pressreleases/21/08/g22271444/immunovant-receives-200-million-strategic-investment-from-roivant-sciences

Category: Contact NumberShow more

Immunovant Receives $200 Million Strategic Investment from

7 hours ago Biospace.com Get All

Proceeds will fund continued development of IMVT-1401 in multiple indications; NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that it has received a $200 million strategic investment from Roivant Sciences.

Website: https://www.biospace.com/article/releases/immunovant-receives-200-million-strategic-investment-from-roivant-sciences/

Category: Contact NumberShow more

Should Immunovant Inc (IMVT) Stock Be in Your Portfolio?

7 hours ago Investorsobserver.com Get All

Immunovant Inc (IMVT) stock is trading at $35.63 as of 10:27 AM on Tuesday, Aug 25, a rise of $2.15, or 6.42% from the previous closing price of $33.48. The stock has traded between $34.02 and $37.00 so far today.

Website: https://www.investorsobserver.com/news/stock-update/should-immunovant-inc-imvt-stock-be-in-your-portfolio-2

Category: Contact NumberShow more

What is Wall Street's Target Price for Immunovant Inc

4 hours ago Investorsobserver.com Get All

Immunovant Inc (IMVT) stock is trading at $8.47 as of 10:09 AM on Monday, Aug 30, a gain of $0.07, or 0.83% from the previous closing price of $8.40. The stock has traded between $8.44 and $8.91 so far today. Volume today is low. So far 179,225 shares have traded compared to average volume of 1,534,309 shares.

Website: https://www.investorsobserver.com/news/stock-update/what-is-wall-streets-target-price-for-immunovant-inc-imvt-stock-monday-2

Category: Contact NumberShow more

Immunovant Announces Redemption of Warrants and

Just Now Biospace.com Get All

These statements are also subject to a number of material risks and uncertainties that are described under the section titled “Risk Factors” in Immunovant’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on February 14, …

Website: https://www.biospace.com/article/releases/immunovant-announces-redemption-of-warrants-and-achievement-of-first-earnout-milestone-under-share-exchange-agreement/

Category: Contact NumberShow more

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

2 hours ago Markets.businessinsider.com Get All

888.476.6529

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e …

Website: https://markets.businessinsider.com/news/stocks/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-of-class-action-lawsuit-and-upcoming-d-1030239352

Category: Contact NumberShow more

Immunovant Inc. (IMVT) Has Strong Growth Prospects Through

2 hours ago Marketingsentinel.com Get All

Immunovant Inc. (NASDAQ:IMVT)’s Major holders. Insiders own 61.01% of the company shares, while shares held by institutions stand at 41.57% with a share float percentage of 106.61%. Investors are also buoyed by the number of investors in a company, with Immunovant Inc. having a total of 190 institutions that hold shares in the company.

Website: https://marketingsentinel.com/2021/08/18/immunovant-inc-imvt-has-strong-growth-prospects-through-2021/

Category: Contact NumberShow more

Immunovant set to land on Nasdaq via HSAC merger

Just Now Fiercebiotech.com Get All

Immunovant is set to land on Nasdaq through a deal with Health Sciences Acquisitions Corporation, a business founded by RTW Investments to buy a …

Website: https://www.fiercebiotech.com/biotech/immunovant-set-land-nasdaq-via-hsac-merger

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is immunovant inc?

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn). Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET).

What was the stock price of immunovant in june?

Will Biotech Stocks’ Slide Become a Rout? June Holds the Key. Immunovant, Inc. (IMVT) Up 6.6% Since Last Earnings Report: Can It Continue?

Is there a class action lawsuit against immunovant?

WILMINGTON, Del., June 28, 2021 (GLOBE NEWSWIRE) -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential securities violations and breach of fiduciary duty claims against Immunovant, Inc. (“Immunovant” or the “Company”) (NASDAQGS: IMVT).

Who is the chief medical officer of immunovant?

He succeeded Rita Jain, M.D., who informed the company of her plans to step down from her position as Chief Medical Officer to pursue another opportunity. Dr. Macias brings over 27 years of pharmaceutical experience to Immunovant, including industry-leading experience in early, mid, and late phase development.

Brand New Updated

Popular Brands

Intel
Icbc
Iqvia
Imcd
Isbank
Idex
Ing
Intuit
Itc
Ipg